CA2369272A1 - Compositions medicinales et leur procede de preparation - Google Patents

Compositions medicinales et leur procede de preparation Download PDF

Info

Publication number
CA2369272A1
CA2369272A1 CA002369272A CA2369272A CA2369272A1 CA 2369272 A1 CA2369272 A1 CA 2369272A1 CA 002369272 A CA002369272 A CA 002369272A CA 2369272 A CA2369272 A CA 2369272A CA 2369272 A1 CA2369272 A1 CA 2369272A1
Authority
CA
Canada
Prior art keywords
composition
glycoalkaloid
group
bec
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002369272A
Other languages
English (en)
Inventor
Bill E. Cham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CURA NOMINEES PTY Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2369272A1 publication Critical patent/CA2369272A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Cette invention se rapporte à une composition médicinale comprenant au moins un composé pouvant interagir avec une cellule cible, ce ou ces composés étant constitués par un glycoalcaloïde, représenté par la formule générale (I), où cette composition est essentiellement exempte de sucres libres empêchant l'interaction entre le ou les glycoalcaloïdes et une cellule cible.
CA002369272A 1999-04-09 2000-04-10 Compositions medicinales et leur procede de preparation Abandoned CA2369272A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP9686 1999-04-09
AUPP9686A AUPP968699A0 (en) 1999-04-09 1999-04-09 Therapeutic compositions and method for their preparation
PCT/AU2000/000300 WO2000061153A1 (fr) 1999-04-09 2000-04-10 Compositions medicinales et leur procede de preparation

Publications (1)

Publication Number Publication Date
CA2369272A1 true CA2369272A1 (fr) 2000-10-19

Family

ID=3813885

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002369272A Abandoned CA2369272A1 (fr) 1999-04-09 2000-04-10 Compositions medicinales et leur procede de preparation

Country Status (4)

Country Link
EP (1) EP1181022A4 (fr)
AU (1) AUPP968699A0 (fr)
CA (1) CA2369272A1 (fr)
WO (1) WO2000061153A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923076D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
EP1430073B1 (fr) 2001-09-28 2005-12-07 GlycoMed Sciences Limited Procede d'extraction de solvant
WO2003030915A1 (fr) * 2001-10-09 2003-04-17 Glycomed Sciences Limited Utilisation de solamargine pour le traitement de tumeurs de la peau
WO2003030884A2 (fr) * 2001-10-09 2003-04-17 Glycomed Sciences Limited Utilisation de solasonine
US6984725B2 (en) 2002-06-28 2006-01-10 Solbec Pharmaceuticals Ltd. Method for the separation of triglycoalkaloids
AUPS326302A0 (en) * 2002-06-28 2002-07-18 Solbec Pharmaceuticals Limited Method for the separation of solamargine and solasonine
AU2003900194A0 (en) * 2003-01-15 2003-01-30 Solbec Pharmaceuticals Limited Methods of modulating il-6
TWI300352B (en) 2003-06-05 2008-09-01 G & E Herbal Biotechnology Co Ltd Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract
EP1508334B1 (fr) * 2003-08-22 2010-03-17 G & E Herbal Biotechnology Co., Ltd. Extrait soluble dans l'eau de solanum, procédé de préparation et composition pharmaceutique de l'extrait hydrosoluble
GB0329667D0 (en) 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0513881D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
EP1858526A1 (fr) * 2005-03-02 2007-11-28 Solbec Pharmaceuticals Limited Combinaisons d'un glycoalcaloïde et d'un agoniste de tlr et diverses applications desdites combinaisons
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
WO2007038421A2 (fr) * 2005-09-27 2007-04-05 University Of Kentucky Research Foundation Preparations et extraits de baies
TWI414304B (zh) * 2011-05-04 2013-11-11 G & E Herbal Biotechnology Co Ltd 使用茄屬植物的水溶性萃取物來治療疣
TWI476012B (zh) * 2011-05-12 2015-03-11 G & E Herbal Biotechnology Co Ltd 使用茄屬植物的水溶性萃取物來治療和／或預防發炎與皮膚光損害以及光防護皮膚
AU2012268036B2 (en) * 2011-06-06 2017-04-06 THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF STATE OF THE DEPARTMENT OF VETERANS AFFAIRS Methods of inhibiting muscle atrophy
CN105192820A (zh) * 2015-08-20 2015-12-30 泰山医学院 一种降血脂蛹虫草多糖饮料及其制备方法
WO2017147659A1 (fr) 2016-03-03 2017-09-08 Bill Elliot Cham Combinaisons de glycoalcaloïdes et leurs diverses utilisations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU540812B2 (en) * 1979-05-02 1984-12-06 Aruba Qld Pty. Ltd. Steroid alkaloids
SG50585A1 (en) * 1990-01-18 1998-07-20 Cura Nominees Pty Ltd Glycoalkaloids

Also Published As

Publication number Publication date
WO2000061153A1 (fr) 2000-10-19
EP1181022A1 (fr) 2002-02-27
AUPP968699A0 (en) 1999-05-06
EP1181022A4 (fr) 2004-02-11

Similar Documents

Publication Publication Date Title
CA2369272A1 (fr) Compositions medicinales et leur procede de preparation
JP3650400B2 (ja) 育毛剤
EP0558509B1 (fr) Utilisation de saponines de medicago pour la preparation de compositions cosmetiques ou pharmaceutiques, notamment dermatologiques favorisant le renouvellement de l'epiderme, stimulant la repousse des cheveux, ou retardant leur chute
US20040220115A1 (en) Medicinal compositions and their method of preparation
KR19990014205A (ko) 플라보노이드 및 파피아 가공물을 함유한 조성물
US7935672B2 (en) Derivatives of genkwanin and sakuranetin, cosmetic and therapeutic use thereof and preparation method of same
HU228799B1 (en) Tanacetum parthenium extract
US6939859B1 (en) Skin preparations for external use
CA2312856C (fr) Utilisation d'extraits de ginkgo biloba pour preparer un medicament
CN108883123B (zh) 配糖生物碱组合及其各种用途
AU779512B2 (en) Medicinal compositions and their method of preparation
JP2006241095A (ja) フィラグリン合成促進剤および紫外線傷害緩和剤
FR2950532A1 (fr) Procede pour la preparation d'un extrait de plantes du genre sclerolobium, composition cosmetique et pharmaceutique comprenant cet extrait et utilisation dudit extrait
RU2795113C1 (ru) Комбинации гликоалкалоидов и различные их применения
KR102014685B1 (ko) 골담초 유래 화합물 및 이를 함유하는 피부 미백용 조성물
CN110840878B (zh) 一种用于治疗银屑病的化合物及其制备方法
US11427611B2 (en) Use of steroidal glycosides, pharmaceutical formulations, use of Furcraea foetida plant extracts, process for producing Furcraea foetida plant extracts and method for treating skin disorders
JP3182047B2 (ja) 黒砂糖より抽出された成分を含む化粧料組成物
JP3792053B2 (ja) 過酸化脂質生成抑制剤及びこれを含有する組成物
JPH10182331A (ja) 化粧料
JP2000198726A (ja) 過酸化脂質生成抑制剤及びこれを含有する組成物
JP3182044B2 (ja) 黒砂糖より抽出された成分を含む化粧料組成物
KR101711512B1 (ko) 피부 개선용 조성물
JP2001302487A (ja) 美白化粧料
WO2003022231A1 (fr) Compositions pour stimuler et favoriser la pousse des cheveux

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 20100930